Nalaganje...
Twin pregnancy outcome following teriflunomide treatment in a relapsing-remitting multiple sclerosis patient: A case report
RATIONALE: Teriflunomide is a disease-modifying drug that has been approved for treatment of relapsing-remitting multiple sclerosis. Due to its teratogenic effect in animals, however, it is not recommended during pregnancy. For this reason, effective contraception must be used during its administrat...
Shranjeno v:
| izdano v: | Medicine (Baltimore) |
|---|---|
| Main Authors: | , , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Wolters Kluwer Health
2020
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7360296/ https://ncbi.nlm.nih.gov/pubmed/32664171 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000021212 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|